Commenting on the biggest patent rulings so far this year, Washington, DC Principal Blair Jacobs said that two recent decisions by judges in the U.K. awarding patent owners relatively low awards based on standard essential patents could make the U.K. an appealing venue for potential licensees. He noted that the decisions may provide incentive for potential licensees "to hold out even further, because they believe they can get a lower rate by pushing the case" to the U.K. He also noted that the Supreme Court decision in Amgen v. Sanofi, which held that broad patents covering anything that can perform a certain function are not allowed, was a relatively rare instance of the justices unanimously affirming the Federal Circuit, and "provides very clear guidance regarding enablement.” Click here to read the full article.
